Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.26 USD | +13.23% | -7.19% | -35.57% |
Sales 2024 * | 11Cr 925.54Cr | Sales 2025 * | 7.15Cr 595.95Cr | Capitalization | 3.98Cr 331.76Cr |
---|---|---|---|---|---|
Net income 2024 * | -8.9Cr -742.15Cr | Net income 2025 * | -12Cr -992.32Cr | EV / Sales 2024 * | 0.19 x |
Net cash position 2024 * | 1.92Cr 160.37Cr | Net cash position 2025 * | 8.81Cr 734.97Cr | EV / Sales 2025 * | -0.68 x |
P/E ratio 2024 * |
-0.49
x | P/E ratio 2025 * |
-0.38
x | Employees | 173 |
Yield 2024 * |
605% | Yield 2025 * |
605% | Free-Float | 90.87% |
Latest transcript on Atara Biotherapeutics, Inc.
1 day | +13.23% | ||
1 week | -7.19% | ||
Current month | -41.09% | ||
1 month | -47.05% | ||
3 months | -52.80% | ||
6 months | -40.99% | ||
Current year | -35.57% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Touchon
CEO | Chief Executive Officer | 61 | 24/19/24 |
Eric Hyllengren
DFI | Director of Finance/CFO | 49 | 01/18/01 |
Anhco Nguyen
CTO | Chief Tech/Sci/R&D Officer | 51 | 10/21/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Gallagher
CHM | Chairman | 59 | 01/13/01 |
William Heiden
BRD | Director/Board Member | 64 | 23/15/23 |
Matthew Fust
BRD | Director/Board Member | 59 | 01/14/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 415 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
27/24/27 | 8.26 | +13.23% | 147,484 |
26/24/26 | 7.295 | -6.23% | 75,835 |
25/24/25 | 7.78 | -6.10% | 133,681 |
24/24/24 | 8.285 | +0.67% | 122,303 |
21/24/21 | 8.23 | -7.53% | 439,055 |
Delayed Quote Nasdaq, June 28, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.57% | 3.98Cr | |
+16.13% | 12TCr | |
+19.65% | 11TCr | |
+21.22% | 2.65TCr | |
-23.84% | 1.94TCr | |
-17.47% | 1.62TCr | |
-45.95% | 1.52TCr | |
-19.28% | 1.54TCr | |
+63.81% | 1.49TCr | |
+1.94% | 1.35TCr |
- Stock Market
- Equities
- ATRA Stock